AstraZeneca PLC AZN
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 23.06% | 2.33% | 5.62% | 55.07% | 77.26% |
| Total Depreciation and Amortization | -5.29% | 14.04% | 6.39% | 85.71% | -14.75% |
| Total Amortization of Deferred Charges | -- | -- | -- | 18.00% | -- |
| Total Other Non-Cash Items | 72.35% | -629.63% | -42.62% | -120.39% | 126.04% |
| Change in Net Operating Assets | -134.97% | -26.96% | -134.74% | -243.14% | 1,936.59% |
| Cash from Operations | -9.12% | -15.39% | -9.53% | -19.44% | 51.76% |
| Capital Expenditure | 1.46% | -15.78% | -27.51% | -46.33% | -64.51% |
| Sale of Property, Plant, and Equipment | -- | -55.56% | 700.00% | 50.00% | -- |
| Cash Acquisitions | -82.93% | 87.64% | 29.01% | 0.36% | -24.71% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 38.20% | -78.00% | -115.12% | 30.35% | -18.35% |
| Cash from Investing | 5.80% | -38.14% | -43.02% | -22.44% | -32.17% |
| Total Debt Issued | 699.43% | -101.86% | 293.45% | -76.92% | 15.18% |
| Total Debt Repaid | -10.75% | -2,107.83% | -12.94% | -1,671.43% | 95.54% |
| Issuance of Common Stock | -20.00% | 50.00% | 25.00% | 0.00% | 25.00% |
| Repurchase of Common Stock | -452.63% | -1,433.33% | -25.93% | -- | 76.54% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -3.48% | 90.00% | 1.79% | -- | -2.22% |
| Other Financing Activities | 766.67% | 100.00% | -169.23% | -1,178.26% | -112.50% |
| Cash from Financing | 112.49% | -600.39% | 109.86% | -389.12% | 49.82% |
| Foreign Exchange rate Adjustments | 41.67% | -68.97% | -172.00% | 106.56% | -160.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 189.41% | -244.11% | 918.02% | -339.64% | 146.74% |